News

Oncology practitioners now have a new drug in their armamentarium to help prevent chemotherapy-induced nausea and vomiting (CINV) following the FDA's approval today of the oral agent rolapitant (Varubi).

Clinicians suggest that telemedicine may be helpful.

Like many advocates of a cause, Amy Byer Shainman's passion came from a place of frustration.

Marguerite Regan, PhD, was diagnosed with Waldenstrom's macroglobulinemia in 1995 and shares practical wisdom from her experiences, including reminding patients that WM isa treatable illness, not an end game.

Ten years after founding The Julie Fund for Women's Cancers, President Peter McAvinn's resolve is stronger than ever.

Listening to music before undergoing ambulatory surgery for the diagnosis or treatment of breast cancer lessens patients' anxiety levels.

Teenagers who use electronic cigarettes by the time that they start high school are more likely to start smoking conventional cigarettes and develop a nicotine addiction within the next year.

For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.

For patients dealing with cancer, a daily dose of inspiration may make a big difference in their outlook on life.

Meta-analysis of 148 studies confirms benefit of spirituality and religion.

Rates of endometrial cancer continue to increase among all racial and ethnic groups, but they're rising faster among non-Hispanic black women who also have poorer outcomes when compared with their white, non-Hispanic counterparts.

Patients with Hodgkin lymphoma at risk of relapse or progression have a new treatment option following the FDA's expansion of the approved use of brentuximab vedotin (Adcetris).

Researchers at Oregon Health & Science University found that breast cancer survivors who experience pain during sexual intercourse may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

Lung cancer at any age is a catastrophic illness, but it is particularly devastating when it affects young adults in the prime of their lives.

A donation from Bristol-Myers Squibb Company to The Leukemia & Lymphoma Society (LLS) will provide financial assistance for chronic myeloid leukemia (CML) patients who need help paying for Polymerase Chain Reaction (PCR) testing.

Study finds long-term survival is not unusual.

Results from the phase III TELESTAR trial showed that oral telotristat etiprate proved much better than placebo in reducing carcinoid syndrome–related diarrhea.

Less than 50% of patients with ovarian cancer who could benefit from intraperitoneal chemotherapy actually receive it, despite research suggesting that this technique could improve survival for these patients.

Guidelines for metastatic breast cancer developed.

Oral contraceptives may provide long-term protection against endometrial cancer.

A study by the Cancer Support Community examined the factors that are most influential when patients choose a particular treatment option.

Though immunotherapies can provide significant survival benefit for patients with lung cancer, using the agents in practice is still unchartered territory for many clinicians.

Physicians appear to be the drivers of hospice care.

A diagnosis of breast cancer is difficult at any age but for younger women, treatment decisions can be especially difficult, with implications that include their future childbearing, sexual health, and body image.

Two web-based interventions that help men with prostate cancer deal with sexual dysfunction and other common side effects of treatment are demonstrating how tech tools can be successfully deployed to address the psychosocial needs of patients, their caregivers, and survivors.

For oncology clinicians and practices who want to meet new standards for more patient-centered cancer care, they need to do a better job of engaging patients more fully in their care planning and make patient-reported outcomes an integral part of cancer treatment research.

The patient-powered research registry ABOUT aims to increase knowledge about the best prevention, diagnostic, and treatment approaches for those affected directly or indirectly by hereditary cancer risk.

Although it is important for clinicians and their patients who are receiving anticancer treatment to discuss patients' fertility preservation options, a new study has found that whether these conversations take place and, importantly, whether ensuing action is taken, depends on a number of factors.